Please use this identifier to cite or link to this item: http://repositorio.unicamp.br/jspui/handle/REPOSIP/199990
Type: Artigo de periódico
Title: Assessment Of The Use Of Two New Low-dose Levonorgestrel-releasing Intrauterine Systems As Contraceptives.
Author: Bahamondes, Luis
Bahamondes, M Valeria
Abstract: Evaluation of: Gemzell-Danielsson K, Schellschmidt I, Apter D. A randomized, Phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena. Fertil. Steril. 97(3), 616-622.e3 (2012). A randomized, open-label, Phase II study was conducted in 37 centers in five European countries to assess the optimal dose for a new contraceptive levonorgestrel intrauterine system (LNG-IUS). Overall, 742 parous or nulliparous women aged 21-40 years were allocated to receive a LNG-IUS that initially releases 12 µg/day (LNG-IUS(12)) or 16 µg/day (LNG-IUS(16)) in vitro or the currently available device that releases 20 µg/day (LNG-IUS(20)). The two new devices are shorter than the current one. Pearl Indices of 0.17, 0.82 and 0.00 for the LNG-IUS(12), LNG-IUS(16) and LNG-IUS(20), respectively, reflect the contraceptive efficacy of these devices. The mean number of bleeding and spotting days decreased in all three groups; however, this decrease was more significant in LNG-IUS(20) users. Placement of the new shorter devices was considered simple by providers, while patients reported significantly less pain with the two new devices compared with the current one. This study provided further insight into the development of two new LNG-IUS devices as contraceptives, with the additional possibility of using them to treat heavy menstrual bleeding or as endometrial protection during estrogen therapy.
Subject: Adult
Contraceptives, Oral, Synthetic
Dose-response Relationship, Drug
Europe
Female
Humans
Intrauterine Devices, Medicated
Levonorgestrel
Metrorrhagia
Pregnancy
Pregnancy, Unplanned
Time Factors
Treatment Outcome
Citation: Women's Health (london, England). v. 8, n. 3, p. 235-8, 2012-May.
Rights: fechado
Identifier DOI: 10.2217/whe.12.12
Address: http://www.ncbi.nlm.nih.gov/pubmed/22554171
Date Issue: 2012
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
File SizeFormat 
pmed_22554171.pdf279.56 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.